Related Content
- Communiqué: Warfarin: Genotyping and Improving Dosing
- Communiqué: How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults
- Communiqué: Importance of Device Evaluation for Point-of-Care Prothrombin Time International Normalized Ratio Testing Programs
- Hot Topic: Warfarin Sensitivity Genotyping
- Hot Topic: The INR and FFP - Is This A Good Relationship With Regard To Transfusion Practice?
- Hot Topic: Preparation of Platelet Poor Plasma for Special Coagulation Testing
- Hot Topic: Preanalytic Variables in Special Coagulation Testing: Clinical Implications
- Hot Topic: Guidelines for Anticoagulation Therapy for Secondary Prevention After Deep Vein Thrombosis
- Hot Topic: The Use of Genetics in Guiding Therapy
- Communiqué: Pharmacogenomics: The Use of Genetics in Guiding Pharmacologic Therapy
External
link
PDF
document
Excel
document
Word
document